Haemonetics Corp (HAE) insider trading
Every open-market stock purchase and sale by Haemonetics Corp executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Mark W Kroll (Director), $98.8K, 11 months ago.
Last 12 months: insiders bought $98.8K (1 buy) and sold $0 (0 sales). Last close $84.82 on Jul 30, 2026.
Recent HAE insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jul 24, 2026 | Robert E Abernathy (Director) | Bought (not open market) | — |
| Jul 24, 2026 | Lloyd Emerson Johnson (Director) | Bought (not open market) | — |
| Jul 24, 2026 | Ellen M Zane (Director) | Bought (not open market) | — |
| Jul 24, 2026 | Michael J Coyle (Director) | Bought (not open market) | — |
| Jul 24, 2026 | Martin D Madaus (Director) | Bought (not open market) | — |
| Jul 24, 2026 | Mark W Kroll (Director) | Bought (not open market) | — |
| Jul 24, 2026 | Diane M Bryant (Director) | Bought (not open market) | — |
| Jul 24, 2026 | Claire Pomeroy (Director) | Bought (not open market) | — |
| Jun 5, 2026 | Laurie A. Miller (VP) | Sold (not open market) | $22.3K |
| Jun 5, 2026 | Farris Maryanne Maunsell (C-suite exec) | Sold (not open market) | $18.5K |
| May 15, 2026 | Christopher Simon (CEO) | Sold (not open market) | $545K |
| May 15, 2026 | Michelle L Basil (VP) | Sold (not open market) | $164K |
| May 15, 2026 | James DArecca (CFO) | Sold (not open market) | $141K |
| May 15, 2026 | Laurie A. Miller (VP) | Sold (not open market) | $53.4K |
| May 15, 2026 | Roy Galvin (C-suite exec) | Sold (not open market) | $49.5K |
| May 15, 2026 | Frank Chan (COO) | Sold (not open market) | $30.7K |
| May 15, 2026 | Farris Maryanne Maunsell (C-suite exec) | Sold (not open market) | $11.1K |
| May 15, 2026 | Roy Galvin (C-suite exec) | Bought (not open market) | — |
| May 15, 2026 | Christopher Simon (CEO) | Bought (not open market) | — |
| May 15, 2026 | Laurie A. Miller (VP) | Bought (not open market) | — |
| May 15, 2026 | James DArecca (CFO) | Bought (not open market) | — |
| May 15, 2026 | Farris Maryanne Maunsell (C-suite exec) | Bought (not open market) | — |
| May 15, 2026 | Frank Chan (COO) | Bought (not open market) | — |
| May 15, 2026 | Michelle L Basil (VP) | Bought (not open market) | — |
| May 1, 2026 | James DArecca (CFO) | Sold (not open market) | $38.8K |
Who's trading HAE
- Ellen M Zane, Director: other filings, last Jul 24, 2026
- Diane M Bryant, Director: other filings, last Jul 24, 2026
- Michael J Coyle, Director: other filings, last Jul 24, 2026
- Lloyd Emerson Johnson, Director: other filings, last Jul 24, 2026
- Mark W Kroll, Director: bought $98.8K (1 buy), last Jul 24, 2026
- Martin D Madaus, Director: other filings, last Jul 24, 2026
- Claire Pomeroy, Director: other filings, last Jul 24, 2026
- Robert E Abernathy, Director: other filings, last Jul 24, 2026
- Farris Maryanne Maunsell, C-suite exec: other filings, last Jun 5, 2026
- Laurie A. Miller, VP: other filings, last Jun 5, 2026
- Roy Galvin, President: other filings, last May 15, 2026
- Michelle L Basil, VP: other filings, last May 15, 2026
- Christopher Simon, CEO: other filings, last May 15, 2026
- Frank Chan, COO: other filings, last May 15, 2026
- James DArecca, CFO: other filings, last May 15, 2026
Get free alerts when an insider at Haemonetics Corp files a new trade →